Back to Journals » Cancer Management and Research » Volume 11

Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer

Total article views   Abstract views HTML views PDF downloads Totals
4,902 Dovepress* 3,461 702+ 833 4,163
PubMed Central* 0 739 278 739
Totals 3,461 1,441 1,111 4,902
*Since 4 January 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar